Hedera Dx
PrivateLast Round
Series A
May 27, 2025
Total Funding Raised
$30.9M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Hedera Dx is a biotechnology company that develops and provides liquid biopsy solutions and software for hospital laboratories to conduct in-house, blood-based cancer testing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics, Clinical Trials
Business Model
B2B
Customer Profile
Hardware + Subscription, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hedera Dx Comparables
Compare Hedera Dx with similar companies based on industry and business-model similarity.
Hedera Dx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 27, 2025 | ||||
| Seed | Sep 21, 2022 |
Key People
Founding team and executive leadership
Hedera Dx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ReykVC | Series A |
| Top Harvest Capital | Seed, Series A |
| Tesi | Series A |
| Air Street Capital | Seed |
| Top Harvest Capital | Seed |
| Eyrir Venture Management | Series A |
| Amino Collective | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 52% MoM, reaching 2.1K.
- Jun 19, 2026
Monthly visitors grew 721% MoM, from 250 to 2.1K.
Recent news
Latest coverage and updates
- hiresJul 1, 2026
Hedera Dx hired Tobias Silberzahn as board member on Jul 1st '25.
Hedera Dx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Hedera Dx's valuation, stock price, and market status.
Is Hedera Dx a public or private company?
Hedera Dx is a private company.
What is the current stock price of Hedera Dx?
Hedera Dx is a private company with no public stock price. No recent secondary market data is available.
How much is Hedera Dx worth (valuation)?
Valuation information for Hedera Dx is not publicly available.
Can I buy Hedera Dx stock?
Hedera Dx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Hedera Dx's last funding round?
Hedera Dx's most recent funding round was Series A on May 27, 2025.
Who are the main investors in Hedera Dx?
Key investors in Hedera Dx include Top Harvest Capital, Vsquared Ventures.
Will Hedera Dx IPO soon?
No public IPO plans have been announced for Hedera Dx.
How can I track Hedera Dx secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hedera Dx's secondary market activity and sign up for updates.